Occudo Quantitative Strategies LP Rubius Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.46 - $1.29 $425 - $1,191	-924 Reduced 4.42%	19,975 $9,000
Q2 2022 Aug 15, 2022	BUY	$0.79 - $5.98 $7,998 - $60,547	10,125 Added 93.98%	20,899 $18,000
Q1 2022 May 16, 2022	BUY	$4.25 - $10.4 $45,789 - $112,049	10,774 New	10,774 $59,000
Q3 2021 Nov 15, 2021	SELL	$17.6 - $25.91 $185,539 - $273,143	-10,542 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$22.26 - $28.43 $234,664 - $299,709	10,542 New	10,542 $257,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.